DGAP-CMS: Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

- Share buy-back - 7^th Interim Report (correction notification)

In the period from July 29, 2019 until and including August 2, 2019, a total of 63,746 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF):

XETRA

Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR

Chi-X Europe

Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including August 2, 2019 therefore amounts to 1,534,327 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., August 5, 2019